Current Report Filing (8-k)
04 November 2021 - 7:31AM
Edgar (US Regulatory)
0001791091
false
0001791091
2021-10-28
2021-10-28
0001791091
TLMD:ClassCommonStockParValueOf0.0001PerShareMember
2021-10-28
2021-10-28
0001791091
TLMD:WarrantsEachExercisableForOneShareOfClassCommonStockFor11.50PerShareMember
2021-10-28
2021-10-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October
28, 2021
SOC TELEMED, INC.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
001-39160
|
|
84-3131208
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
1768 Business Center Drive, Suite 100
Reston, Virginia 20190
(Address of principal executive offices,
including zip code)
Registrant’s telephone number, including
area code: (866) 483-9690
Not Applicable
(Former name or former address, if changed since
last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol
|
|
Name of each exchange on which registered
|
Class A Common Stock, par value of $0.0001 per share
|
|
TLMD
|
|
The Nasdaq Stock Market LLC
|
Warrants, each exercisable for one share of Class A Common Stock for $11.50 per share
|
|
TLMDW
|
|
The Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
|
Item 2.05
|
Costs Associated with Exit or Disposal Activities.
|
On October 28, 2021, the Board of Directors of SOC
Telemed, Inc. (the “Company”) approved certain strategic, operational and organizational plans to improve productivity and
reduce complexity in the way the Company manages its business. In connection with these actions, the Company expects to reduce non-clinical
headcount by approximately 12%. The Company also plans to downsize, vacate or close certain facilities and terminate certain contracts
in connection with the restructuring plan. The Company estimates that it will incur up to $3 million in costs in connection with the restructuring,
approximately $2 million for severance and termination benefits and approximately $1 million for site closures and other exit and disposal
costs. These actions are expected to be substantially completed by the end of 2021. The Company estimates annualized benefits from the
restructuring plan of approximately $7-9 million after calendar year 2021.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
SOC Telemed, Inc.
|
|
|
Date: November 3, 2021
|
By:
|
/s/ Eunice Kim
|
|
Name:
|
Eunice Kim
|
|
Title:
|
General Counsel and Corporate Secretary
|
2
SOC Telemed (NASDAQ:TLMD)
Historical Stock Chart
From Oct 2024 to Nov 2024
SOC Telemed (NASDAQ:TLMD)
Historical Stock Chart
From Nov 2023 to Nov 2024